A detailed history of Treasurer Of The State Of North Carolina transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Treasurer Of The State Of North Carolina holds 1,066,218 shares of BMY stock, worth $62.4 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
1,066,218
Previous 1,055,818 0.99%
Holding current value
$62.4 Million
Previous $43.8 Million 25.81%
% of portfolio
0.22%
Previous 0.19%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $412,463 - $538,200
10,400 Added 0.99%
1,066,218 $55.2 Million
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $637,962 - $839,891
-15,850 Reduced 1.48%
1,055,818 $43.8 Million
Q1 2024

May 09, 2024

BUY
$47.98 - $54.4 $663,563 - $752,352
13,830 Added 1.31%
1,071,668 $58.1 Million
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $242,206 - $289,018
-4,996 Reduced 0.47%
1,057,838 $54.3 Million
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $930,350 - $1.04 Million
16,071 Added 1.54%
1,062,834 $61.7 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $1.38 Million - $1.54 Million
21,738 Added 2.12%
1,046,763 $66.9 Million
Q1 2023

May 04, 2023

BUY
$65.71 - $74.53 $1.26 Million - $1.43 Million
19,202 Added 1.91%
1,025,025 $71 Million
Q4 2022

Feb 09, 2023

BUY
$68.48 - $81.09 $2.92 Million - $3.46 Million
42,629 Added 4.43%
1,005,823 $72.4 Million
Q3 2022

Nov 08, 2022

BUY
$0.13 - $76.84 $1,166 - $689,254
8,970 Added 0.94%
963,194 $68.5 Million
Q2 2022

Aug 02, 2022

SELL
$72.62 - $79.98 $469,343 - $516,910
-6,463 Reduced 0.67%
954,224 $73.5 Million
Q1 2022

May 10, 2022

SELL
$61.48 - $73.72 $1.24 Million - $1.49 Million
-20,230 Reduced 2.06%
960,687 $70.2 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $275,658 - $321,352
5,140 Added 0.53%
980,917 $61.2 Million
Q3 2021

Nov 03, 2021

BUY
$59.17 - $69.31 $149,108 - $174,661
2,520 Added 0.26%
975,777 $57.7 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $1.18 Million - $1.29 Million
-19,110 Reduced 1.93%
973,257 $65 Million
Q1 2021

May 03, 2021

BUY
$59.34 - $66.74 $190,481 - $214,235
3,210 Added 0.32%
992,367 $62.6 Million
Q4 2020

Feb 02, 2021

BUY
$57.74 - $65.43 $238,466 - $270,225
4,130 Added 0.42%
989,157 $61.4 Million
Q3 2020

Nov 04, 2020

BUY
$57.43 - $63.64 $200,430 - $222,103
3,490 Added 0.36%
985,027 $59.4 Million
Q2 2020

Aug 07, 2020

SELL
$54.82 - $64.09 $9.94 Million - $11.6 Million
-181,250 Reduced 15.59%
981,537 $57.7 Million
Q1 2020

May 13, 2020

BUY
$46.4 - $67.43 $3.78 Million - $5.49 Million
81,420 Added 7.53%
1,162,787 $64.8 Million
Q4 2019

Feb 12, 2020

BUY
$49.21 - $64.19 $16.2 Million - $21.1 Million
329,377 Added 43.8%
1,081,367 $69.4 Million
Q3 2019

Nov 07, 2019

SELL
$42.77 - $50.71 $13.2 Million - $15.6 Million
-308,240 Reduced 29.07%
751,990 $38.1 Million
Q2 2019

Aug 23, 2019

SELL
$44.62 - $49.34 $386,409 - $427,284
-8,660 Reduced 0.81%
1,060,230 $48.1 Million
Q1 2019

Aug 07, 2019

BUY
$45.12 - $53.8 $176,735 - $210,734
3,917 Added 0.37%
1,068,890 $51 Million
Q4 2018

Aug 07, 2019

BUY
$48.76 - $63.23 $586,826 - $760,973
12,035 Added 1.14%
1,064,973 $55.4 Million
Q3 2018

Aug 07, 2019

BUY
$55.19 - $62.25 $20.9 Million - $23.6 Million
379,083 Added 56.26%
1,052,938 $65.4 Million
Q2 2018

Aug 07, 2019

BUY
$50.53 - $62.98 $21.1 Million - $26.3 Million
418,037 Added 163.41%
673,855 $37.3 Million
Q1 2018

Jul 24, 2019

BUY
$59.92 - $68.98 $15 Million - $17.3 Million
251,116 Added 5340.62%
255,818 $16.2 Million
Q4 2017

May 06, 2019

BUY
$59.94 - $65.35 $281,837 - $307,275
4,702
4,702 $288,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Treasurer Of The State Of North Carolina Portfolio

Follow Treasurer Of The State Of North Carolina and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Treasurer Of The State Of North Carolina, based on Form 13F filings with the SEC.

News

Stay updated on Treasurer Of The State Of North Carolina with notifications on news.